Llwytho...
Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
Malignant pleural mesothelioma (MPM) tumors are remarkably aggressive and most patients only survive for 5–12 months; irrespective of stage; after primary symptoms appear. Compounding matters is that MPM remains unresponsive to conventional standards of care; including radiation and chemotherapy. Cu...
Wedi'i Gadw mewn:
Cyhoeddwyd yn: | Int J Mol Sci |
---|---|
Prif Awduron: | , , , |
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
MDPI
2018
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5796186/ https://ncbi.nlm.nih.gov/pubmed/29342862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19010238 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|